Search    Show all


1 People found

filters applied:

Details

1 / 1

EMBO Member

Alberto Bardelli

Università di Torino | Italy

EMBO 2017

Precision oncology, cancer genomics

When metastatic cancers are challenged with targeted agents, almost invariably a subset of cells insensitive to the drug emerges. As a result targeted therapies are often only transiently effective in patients. How can we overcome the near-certainty of disease recurrence following treatment with targeted agents? Addressing this question means considering as a target not 'only' individual oncogenes but also the evolving nature of human tumors.

Keywords: Colorectal cancer / genomics / resistance to therapy / liquid biopsies / cancer models

Subject area(s): Signal Transduction | Molecular Medicine | Genomic & Computational Biology

EMBOwords